Terms: = Brain cancer AND BLM, MGC131620, 641, ENSG00000197299, MGC131618, RECQ2, RECQL2, RECQL3, MGC126616, BS AND Staging
4 results:
1. Identification of predictors for brain metastasis in newly diagnosed non-small cell lung cancer: a single-center cohort study.
Park S; Lee SM; Ahn Y; Kim M; Suh CH; Do KH; Seo JB
Eur Radiol; 2022 Feb; 32(2):990-1001. PubMed ID: 34378076
[TBL] [Abstract] [Full Text] [Related]
2. blm germline and somatic PKMYT1 and AHCY mutations: Genetic variations beyond MYCN and prognosis in neuroblastoma.
Novak EM; Halley NS; Gimenez TM; Rangel-Santos A; Azambuja AM; Brumatti M; Pereira PL; Vince CS; Giorgi RR; Bendit I; Cristofani LM; Odone-Filho V
Med Hypotheses; 2016 Dec; 97():22-25. PubMed ID: 27876123
[TBL] [Abstract] [Full Text] [Related]
3. Appropriateness of imaging for lung cancer staging in a national cohort.
Backhus LM; Farjah F; Varghese TK; Cheng AM; Zhou XH; Wood DE; Kessler L; Zeliadt SB
J Clin Oncol; 2014 Oct; 32(30):3428-35. PubMed ID: 25245440
[TBL] [Abstract] [Full Text] [Related]
4. 111In-pentetreotide versus bone scintigraphy in the detection of bony metastases of neuroblastoma.
Juweid ME; Menda Y; O'Dorisio MS; Bushnell D; Blake M; Madsen M; Johnson J; Graham MM
Nucl Med Commun; 2002 Oct; 23(10):983-9. PubMed ID: 12352597
[TBL] [Abstract] [Full Text] [Related]